Phase Holographic Imaging PHI AB (publ)

DB:L5W Stock Report

Market Cap: €15.3m

Phase Holographic Imaging PHI Past Earnings Performance

Past criteria checks 0/6

Phase Holographic Imaging PHI has been growing earnings at an average annual rate of 3.5%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 23.1% per year.

Key information

3.5%

Earnings growth rate

15.2%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate23.1%
Return on equity-3,687.9%
Net Margin-184.8%
Last Earnings Update31 Oct 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Phase Holographic Imaging PHI makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:L5W Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Oct 2411-20187
31 Jul 249-22187
30 Apr 2411-20178
31 Jan 2411-23167
31 Oct 239-22167
31 Jul 2311-22187
30 Apr 2310-23197
31 Jan 239-26178
31 Oct 229-28199
31 Jul 228-27179
30 Apr 228-25179
31 Jan 229-22199
31 Oct 217-21169
31 Jul 216-221610
30 Apr 214-241612
31 Jan 212-231413
31 Oct 203-241512
31 Jul 203-261613
30 Apr 204-261514
31 Jan 205-261514
31 Oct 195-261514
31 Jul 194-261513
30 Apr 195-231312
31 Jan 195-211212
31 Oct 185-181011
31 Jul 185-1599
30 Apr 184-1489
31 Jan 183-1488
31 Oct 173-1377
31 Jul 174-1277
30 Apr 174-1075
31 Jan 174-1075
31 Oct 164-1084
31 Jul 164-1083
30 Apr 164-973
31 Jan 163-872
31 Oct 153-973
31 Jul 153-863
30 Apr 153-963
31 Jan 153-892
31 Oct 143-891
31 Jul 144-781
30 Apr 144-880

Quality Earnings: L5W is currently unprofitable.

Growing Profit Margin: L5W is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: L5W is unprofitable, but has reduced losses over the past 5 years at a rate of 3.5% per year.

Accelerating Growth: Unable to compare L5W's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: L5W is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: L5W has a negative Return on Equity (-3687.89%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 20:59
End of Day Share Price 2024/12/23 00:00
Earnings2024/10/31
Annual Earnings2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Phase Holographic Imaging PHI AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution